Skip to main content
. 2020 Apr 14;40(4):181–193. doi: 10.1002/cac2.12024

FIGURE 4.

FIGURE 4

Kaplan–Meier estimates of invasive disease‐free survival curves for patients with an RS (Surexam® 21‐gene) of 0‐25 (low risk) and patients with an RS (Surexam® 21‐gene) of 26‐100 (high risk). a all patients; b patients older than 50 years of age; c patients 50 years of age or younger.

Abbreviations: RS recurrence score